141 related articles for article (PubMed ID: 29778427)
1. Genomics driven approach for identification of novel therapeutic targets in Salmonella enterica.
Gawade P; Ghosh P
Gene; 2018 Aug; 668():211-220. PubMed ID: 29778427
[TBL] [Abstract][Full Text] [Related]
2. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
3. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
4. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic analysis and characterization of incompatibility group FIB plasmid encoded virulence factors of Salmonella enterica isolated from food sources.
Khajanchi BK; Hasan NA; Choi SY; Han J; Zhao S; Colwell RR; Cerniglia CE; Foley SL
BMC Genomics; 2017 Aug; 18(1):570. PubMed ID: 28768482
[TBL] [Abstract][Full Text] [Related]
7. Unraveling novel broad-spectrum antibacterial targets in food and waterborne pathogens using comparative genomics and protein interaction network analysis.
Jadhav A; Shanmugham B; Rajendiran A; Pan A
Infect Genet Evol; 2014 Oct; 27():300-8. PubMed ID: 25128740
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomics of transport proteins in probiotic and pathogenic Escherichia coli and Salmonella enterica strains.
Do J; Zafar H; Saier MH
Microb Pathog; 2017 Jun; 107():106-115. PubMed ID: 28344124
[TBL] [Abstract][Full Text] [Related]
9. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
10. Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in Europe.
Huehn S; La Ragione RM; Anjum M; Saunders M; Woodward MJ; Bunge C; Helmuth R; Hauser E; Guerra B; Beutlich J; Brisabois A; Peters T; Svensson L; Madajczak G; Litrup E; Imre A; Herrera-Leon S; Mevius D; Newell DG; Malorny B
Foodborne Pathog Dis; 2010 May; 7(5):523-35. PubMed ID: 20039795
[TBL] [Abstract][Full Text] [Related]
11. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica.
Gerlach RG; Hensel M
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):317-27. PubMed ID: 17715824
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel therapeutic target and epitopes through proteome mining from essential hypothetical proteins in Salmonella strains: An In silico approach towards antivirulence therapy and vaccine development.
Sah PP; Bhattacharya S; Banerjee A; Ray S
Infect Genet Evol; 2020 Sep; 83():104315. PubMed ID: 32276082
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of FDA approved drugs and their validation against potential drug targets for
Kesharwani A; Chaurasia DK; Katara P
J Biomol Struct Dyn; 2022 Sep; 40(14):6255-6271. PubMed ID: 33525976
[No Abstract] [Full Text] [Related]
14. Pathogenicity and phenotypic analysis of sopB, sopD and pipD virulence factors in Salmonella enterica serovar typhimurium and Salmonella enterica serovar Agona.
Khoo CH; Sim JH; Salleh NA; Cheah YK
Antonie Van Leeuwenhoek; 2015 Jan; 107(1):23-37. PubMed ID: 25312847
[TBL] [Abstract][Full Text] [Related]
15. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
16. Caenorhabditis elegans-based screen identifies Salmonella virulence factors required for conserved host-pathogen interactions.
Tenor JL; McCormick BA; Ausubel FM; Aballay A
Curr Biol; 2004 Jun; 14(11):1018-24. PubMed ID: 15182677
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomics reveals different population structures associated with host and geographic origin in antimicrobial-resistant Salmonella enterica.
Liao J; Orsi RH; Carroll LM; Wiedmann M
Environ Microbiol; 2020 Jul; 22(7):2811-2828. PubMed ID: 32337816
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of the therapeutic drug targets of C. botulinum ATCC 3502 and C. difficile str. 630 using in silico subtractive proteomics approach.
Bhardwaj T; Haque S; Somvanshi P
J Cell Biochem; 2019 Sep; 120(9):16160-16184. PubMed ID: 31081164
[TBL] [Abstract][Full Text] [Related]
19. [Occurrence and characterization of monophasic Salmonella enterica subsp. enterica with antigenic formula 1,4, [5], 12: i:-isolated in Poland in 2007-2012].
Madajczak G; Wołkowicz T; Dera-Tomaszewska B; Wasiak M; Chróst A; Szych J
Med Dosw Mikrobiol; 2014; 66(2):65-78. PubMed ID: 25369653
[TBL] [Abstract][Full Text] [Related]
20. Functional Divergence of the Paralog
Oke MT; D'Costa VM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
